Equities

Movano Inc

MOVE:NAQ

Movano Inc

Actions
  • Price (USD)0.5126
  • Today's Change0.026 / 5.32%
  • Shares traded49.76k
  • 1 Year change-50.22%
  • Beta--
Data delayed at least 15 minutes, as of May 02 2024 20:58 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Movano Inc., doing business as Movano Health, is engaged in developing a suite of healthcare solutions to bring medical-grade data to the forefront of wearables. Its devices deliver data to both customers and enterprises, capturing a comprehensive picture of an individual’s health data and translating it into personalized and intelligent insights. Its product in development is the Evie Ring, which is a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one’s health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It is also developing System-on-a-Chip (SoC) designed specifically for blood pressure or continuous glucose monitoring (CGM) systems.

  • Revenue in USD (TTM)0.00
  • Net income in USD-29.28m
  • Incorporated2018
  • Employees30.00
  • Location
    Movano Inc6800 Koll Center Parkway, Suite 300PLEASANTON 94566United StatesUSA
  • Phone+1 (408) 393-1209
  • Fax+1 (302) 636-5454
  • Websitehttps://movanohealth.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Eyenovia Inc3.79k-27.26m47.77m57.00--4.75--12,603.67-0.6639-0.66390.000090.19760.0001--0.003166.49-91.15-80.31-119.11-117.700.00---719,290.30-680.952.16-15.140.6135------2.68--152.20--
Rockwell Medical Inc80.83m-9.29m47.86m253.00--2.16--0.5922-0.5462-0.54624.260.75531.5113.839.66319,494.10-17.40-53.82-28.13-73.1010.111.75-11.49-46.171.06-6.740.3517--17.574.9142.83---30.09--
Ocean Biomedical Holdings Inc0.00-45.58m48.51m9.00---------1.40-1.400.00-0.0642------0.00-----------------------------612.50------
Medicine Man Technologies Inc172.45m-42.70m48.51m729.00--0.3844--0.2813-1.60-1.603.011.610.50643.9939.49236,553.90-10.15-8.33-11.95-9.8544.0845.57-20.03-15.710.50270.31430.5679--8.2078.78-62.56--200.89--
Aadi Bioscience Inc24.35m-65.77m49.60m74.00--0.4715--2.04-2.44-2.440.90494.280.15380.67796.63273,640.40-41.54-50.25-48.46-56.1588.47---270.04-473.974.48--0.00--60.063.85-8.68--153.54--
Modular Medical Inc0.00-16.76m49.63m37.00--8.87-----0.9653-0.96530.000.18050.00----0.00-224.40-168.16-262.22-209.51------------0.00------25.51--154.53--
Hcw Biologics Inc2.84m-24.99m49.93m45.00--3.53--17.57-0.6953-0.69530.07910.37370.0755--2.9163,150.89-66.37---78.58--19.72---879.53-----90.860.319---57.72---67.74------
Odonate Inc0.00-102.07m50.02m137.00--1,844.41-----13.59-13.590.009.270.00----0.00-66.98-58.36-83.00-65.14------------0.00-------12.99------
Correlate Energy Corp7.56m-12.79m50.15m19.00------6.63-0.3554-0.35540.21-0.08772.22--13.19398,051.60-375.16-315.47----18.2715.42-169.09-201.03---0.72398.30--122.2046.12-78.54------
Movano Inc0.00-29.28m50.35m30.00--8.30-----0.6463-0.64630.000.06180.00----0.00-258.41-151.50-496.87-188.58--------1.26--0.014------3.45--4.24--
Journey Medical Corp79.18m-3.85m50.57m58.00--3.45--0.6387-0.3502-0.35024.191.050.87012.193.651,365,190.00-4.23---10.51--66.33---4.87--1.100.68630.4641--7.48--87.00------
Checkpoint Therapeutics Inc103.00k-51.85m52.82m23.00------512.77-2.93-2.930.0055-0.47030.011----4,478.26-555.46-142.43---342.79-----50,336.89-6,554.97---------46.35-50.6117.21------
Gain Therapeutics Inc55.18k-22.27m52.89m29.00--3.78--958.54-1.74-1.740.00420.77610.0026--0.25441,902.76-104.28---132.41-------40,354.33-13,827.07----0.0432---60.6221.77-26.59--13.96--
Data as of May 02 2024. Currency figures normalised to Movano Inc's reporting currency: US Dollar USD

Institutional shareholders

17.26%Per cent of shares held by top holders
HolderShares% Held
Mairs & Power, Inc.as of 31 Dec 20233.75m7.39%
The Vanguard Group, Inc.as of 31 Dec 20231.80m3.55%
AWM Investment Co., Inc.as of 31 Dec 20231.36m2.69%
Raymond James Financial Services Advisors, Inc.as of 31 Mar 2024535.80k1.06%
Mirador Capital Partners LPas of 31 Mar 2024413.20k0.81%
Geode Capital Management LLCas of 31 Dec 2023332.64k0.66%
Robert W. Baird & Co., Inc. (Private Banking)as of 31 Dec 2023228.00k0.45%
EP Wealth Advisors LLCas of 31 Dec 2023128.75k0.25%
FNY Capital Management LPas of 31 Dec 2023112.97k0.22%
BlackRock Fund Advisorsas of 31 Dec 202398.17k0.19%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.